开发MPS1抑制剂:最近的进展和前景
Yangjie Zeng1, Xiaodong Ren1, Pengyao Jin1
1Medical College, Guizhou University, Guiyang, Guizhou 550025, China.
Journal of medicinal chemistry
|December 14, 2023
概括
单极旋激酶1 (MPS1) 对于细胞分裂至关重要,在癌症中经常过度表达. 抑制MPS1对癌症治疗具有前景,但开发有效药物仍然具有挑战性.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 药物发现 药物发现 药物发现
背景情况:
- 单极螺旋激酶1 (MPS1) 是一种双特异性激酶,对线粒分裂至关重要,调节螺旋组合检查点 (SAC) 激活和姐妹染色体分离.
- 过度表达MPS1与形积分和各种人类癌症的生存有关,使其成为一个重要的治疗点.
- 尽管它具有治疗潜力,但在开发临床批准的MPS1抑制剂方面仍然存在挑战.
研究的目的:
- 提供MPS1在癌症中的结构,功能和作用的概述.
- 探索各种MPS1抑制剂的结构-活性关系,选择性和药理动力学.
- 审查提高MPS1抑制剂选择性的策略,以改善癌症治疗.
主要方法:
- 关于MPS1在癌症中的作用的文献综述.
- 对各种MPS1抑制剂支架的结构-活性关系的分析.
- 检查MPS1抑制剂的药理动力学特性和选择性增强策略.
主要成果:
- 通过降低SAC敏感度,MPS1的过度表达有助于瘤细胞的存活.
- 已经确定了许多具有多种支架的MPS1抑制剂,但临床转化是有限的.
- 提高抑制剂选择性的策略对于开发强效小分子药物至关重要.
结论:
- 由于MPS1在线粒分裂和形形成中的作用,MPS1是经过验证的癌症标.
- 对MPS1抑制剂选择性和药理动力学的进一步研究对于临床成功至关重要.
- 开发新型,高效的小分子MPS1抑制剂对未来的癌症疗法具有前景.
相关概念视频
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).